Evidence map›Paper›PMID 29880013›Full record

ArticleArthritis research & therapy2018

Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis.

Estefanía Armas-González, María Jesús Domínguez-Luis, Ana Díaz-Martín, Mayte Arce-Franco, Javier Castro-Hernández, Gabriela Danelon, Vanesa Hernández-Hernández, Sagrario Bustabad-Reyes, Alberto Cantabrana, Mariagrazia Uguccioni and 1 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Circulating and Urinary CCL20 in Human Kidney Disease.International journal of molecular sciences · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Estefanía Armas-GonzálezServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
María Jesús Domínguez-LuisServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Ana Díaz-MartínServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Mayte Arce-FrancoServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Javier Castro-HernándezServicio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Gabriela DanelonInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Vanesa Hernández-HernándezServivio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Sagrario Bustabad-ReyesServivio de Reumatología, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain.
Alberto CantabranaServicio de Reumatología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, Spain.
Mariagrazia UguccioniInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Federico Díaz-GonzálezDepartamento de Medicina Interna, Facultad de Medicina, Universidad de La Laguna, La Laguna, Tenerife, Spain. federico.diaz.gonzalez@gmail.com.ORCID 0000-0002-4139-9295
Hospital Universitario de Canarias · ESHospital Universitario Nuestra Señora de Candelaria · ESHumanitas University · ITUniversidad de La Laguna · ESUniversità della Svizzera italiana · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundB cells exert their pathogenic action in rheumatoid arthritis (RA) locally in the synovium. This study was undertaken to elucidate the chemokines responsible for the recruitment of B cells in the inflamed synovium, taking into account that the rich chemokine milieu present in the synovial tissue can fine-tune modulate discrete chemokine receptors.

methodsExpression levels of chemokine receptors from the CC and CXC family, as well as CD27, were assessed by flow cytometry in CD20

resultsB cells from the SF of arthritis patients showed a significant increase in the surface expression of CCR1, CCR2, CCR4, CCR5 and CXCR4 with respect to PB. Conversely, SF B cells expressed consistently lower amounts of CXCR5, CXCR7 and CCR6, independent of CD27 expression. Analysis of permeabilized B cells suggested internalization of CXCR5 and CCR6 in SF B cells. In Transwell experiments, CCL20 and CXCL13, ligands of CCR6 and CXCR5, respectively, caused a significantly higher migration of B cells from PB than of those from SF of RA patients. Together, these two chemokines synergistically increased B-cell migration from PB, but not from SF.

conclusionsThese results suggest that CXCL13 and CCL20 might play major roles in RA pathogenesis by acting singly on their selective receptors and synergistically in the accumulation of B cells within the inflamed synovium.

Indexed as

AdolescentAdultAgedAged, 80 and overArthritis, RheumatoidB-LymphocytesCell MovementCells, CulturedChemokine CCL20Chemokine CXCL13FemaleHumansInflammationMaleMiddle AgedSynovial FluidCCL20 protein, humanChemokine CCL20Chemokine CXCL13CXCL13 protein, humanB cellsChemokines and chemokine receptorsPsoriatic arthritisRheumatoid arthritis

Identifiers

PMID29880013
PMCPMC5992813
OpenAlexW2806428281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.